OpenVSafe by OpenVAERS
Search V-safe

9DV-32539-47186

2 vaccinations 14 coded responses 20 check-ins 13 free-text entries 7 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
147 / NY
Registered
2021-09-22
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-08-31
    Dose 1 — Janssen/Johnson & Johnson
  2. 2021-09-22
    Registered in v-safe
  3. 2021-09-22
    Survey response — day 21, single dose
    MedDRA: Malaise, Pain, Pyrexia — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Fever of 102.5f, body aches, malaise.
    MedDRA releases: 2024-11 · check-in free text available
  4. 2021-09-28
    Health check-in — day 28, single dose
    Feeling: Fair
    Adult check-in
  5. 2021-10-05
    Survey response — day 35, single dose
    MedDRA: Chest discomfort, Cough, Pain, Rhinorrhoea — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Cough, chest tightness, runny nose, body aches.
    MedDRA releases: 2024-11 · check-in free text available
  6. 2021-10-12
    Health check-in — day 42, single dose
    Feeling: Fair
    Adult check-in
  7. 2021-12-02
    Survey response — 3 months, dose 1
    MedDRA: Breast discharge, Breast pain, Lymph node pain, Lymphadenopathy, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Breast discharge and pain. Also, lymph node swelling and pain. · Healthcare visit (other): In person visit at office
    MedDRA releases: 2024-11 · check-in free text available
  8. 2021-12-02
    Report sent to call center — 3 months, dose 1
    Get care from a doctor or other healthcare professional
    1 call case(s)
  9. 2021-12-07
    Call successful
    Participant prefers to complete VAERS report online
  10. 2022-01-20
    Dose 2 — Pfizer-BioNTech
  11. 2022-01-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  12. 2022-01-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  13. 2022-01-23
    Survey response — days 1–6 daily, dose 2
    MedDRA: Oropharyngeal pain — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Sore throat
    MedDRA releases: 2024-11 · check-in free text available
  14. 2022-01-24
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chest pain, Oropharyngeal pain — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Joint pains, Muscle or body aches, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Chest pain, sore throat
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-01-24
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  16. 2022-01-25
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chest pain, Oropharyngeal pain — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Chest pain, sore throat
    MedDRA releases: 2024-11 · check-in free text available
  17. 2022-01-26
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chest pain, Oropharyngeal pain — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Chest pain, sore throat
    MedDRA releases: 2024-11 · check-in free text available
  18. 2022-01-26
  19. 2022-01-27
    Survey response — day 7, dose 2
    MedDRA: Chest pain — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Chest pain
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-02-05
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  21. 2022-02-11
    Health check-in — day 21, dose 2
    Feeling: Fair
    Adult check-in
  22. 2022-02-19
    Survey response — day 28, dose 2
    MedDRA: Bradycardia, Dyspnoea, Hypotension — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Shortness of breath, new hypotension, new bradycardia.
    MedDRA releases: 2024-11 · check-in free text available
  23. 2022-02-24
    Survey response — day 35, dose 2
    MedDRA: Bradycardia, Dehydration, Hypotension, Nausea, Vomiting — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Hypotension, bradycardia, worsened nausea, vomiting, dehydration.
    MedDRA releases: 2024-11 · check-in free text available
  24. 2022-02-24
    Report sent to call center — day 35, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  25. 2022-03-01
  26. 2022-03-03
    Survey response — day 42, dose 2
    MedDRA: Brain fog, Dizziness, Nausea, Vomiting — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Nausea, dizziness, vomiting, brain fog
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-03-03
    Report sent to call center — day 42, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Emergency room or emergency department visit · 1 call case(s)
  28. 2022-03-04
  29. 2022-04-24
    Survey response — 3 months, dose 2
    MedDRA: Breast neoplasm, Breast operation — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Left Breast tumors that required biopsy and now surgery.
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-04-24
    Report sent to call center — 3 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  31. 2022-04-25
  32. 2022-07-23
    Survey response — 6 months, dose 2
    MedDRA: Breast neoplasm, Office visit, Surgery — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Breast tumor · Healthcare visit (other): In person visit and surgery
    MedDRA releases: 2024-11 · check-in free text available
  33. 2022-07-23
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  34. 2022-07-25
  35. 2022-07-25
  36. 2022-07-25
  37. 2022-07-25
  38. 2022-07-25
  39. 2023-01-20
    Survey response — 12 months, dose 2
    MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2024-11
  40. 2023-01-20
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  41. 2023-01-23
  42. 2023-01-23
  43. 2023-01-23
  44. 2023-01-23
  45. 2023-01-23
  46. 2023-01-23

Vaccinations

DoseDateManufacturerCo-administered
12021-08-31Janssen/Johnson & Johnson No
22022-01-20Pfizer-BioNTech No

Call center

7 call center cases

1 successful · 6 unsuccessful

See the call center timeline

Free text

Release 9 — day 21, single dose

2021-09-22

Symptoms: Fever of 102.5f, body aches, malaise.

Release 10 — day 35, single dose

2021-10-05

Symptoms: Cough, chest tightness, runny nose, body aches.

Release 10 — 3 months, dose 1

2021-12-02

Symptoms: Breast discharge and pain. Also, lymph node swelling and pain.
Healthcare visit (other): In person visit at office

Release 11 — days 1–6 daily, dose 2

2022-01-23

Systemic reaction (other): Sore throat

2022-01-24

Systemic reaction (other): Chest pain, sore throat

2022-01-25

Systemic reaction (other): Chest pain, sore throat

2022-01-26

Systemic reaction (other): Chest pain, sore throat

Release 11 — day 7, dose 2

2022-01-27

Systemic reaction (other): Chest pain

Release 11 — day 28, dose 2

2022-02-19

Symptoms: Shortness of breath, new hypotension, new bradycardia.

Release 11 — day 35, dose 2

2022-02-24

Symptoms: Hypotension, bradycardia, worsened nausea, vomiting, dehydration.

Release 11 — day 42, dose 2

2022-03-03

Symptoms: Nausea, dizziness, vomiting, brain fog

Release 11 — 3 months, dose 2

2022-04-24

Symptoms: Left Breast tumors that required biopsy and now surgery.

Release 12 — 6 months, dose 2

2022-07-23

Symptoms: Breast tumor
Healthcare visit (other): In person visit and surgery

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
HCVOSurgery · · ✓
SDBradycardia · · ✓
SDBrain fog · · ✓
SDBreast discharge · · ✓
SDBreast neoplasm · · ✓
SDBreast operation · · ✓
SDBreast pain · · ✓
SDChest discomfort · · ✓
SDCough · · ✓
SDCOVID-19 · · ✓
SDDehydration · · ✓
SDDizziness · · ✓
SDDyspnoea · · ✓
SDHypotension · · ✓
SDLymph node pain · · ✓
SDLymphadenopathy · · ✓
SDMalaise · · ✓
SDNausea · · ✓
SDPain · · ✓
SDPyrexia · · ✓
SDRhinorrhoea · · ✓
SDVomiting · · ✓
SROChest pain · · ✓
SROOropharyngeal pain · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release